Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-01-21

Clinical Trial Update: The Effect of Theraworx Foam in Carpal Tunnel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Theraworx Foam for Carpal Tunnel Syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TheraWorx Foam

Snippet

Sponsor: John Fowler | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: WITHDRAWN